Alterations of the PPP2R1B gene in human lung and colon cancer

Science

Volumn 282, Issue 5387, 1998, Pages 284-287

  Wang, Steven Siqing ^a   Esplin, Edward D ^a   Li, Jia Ling ^a   Huang, Liying ^a   Gazdar, Adi ^a   Minna, John ^a   Evans, Glen A ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 11Q; COLON CANCER; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; HUMAN; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; CELL CYCLE; CELL DIVISION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; COLONIC NEOPLASMS; FRAMESHIFT MUTATION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEIN PHOSPHATASE; POINT MUTATION; SEQUENCE DELETION; TUMOR CELLS, CULTURED;

EID: 0032500792     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.282.5387.284     Document Type: Article

References (33)

1. S. L. Parker, T. Tong, S. Bolden, P. A. Wingo, CA-Cancer J. Clin. 47, 5 (1997).
2. Y. Arai, F. Hosoda, K. Nakayama, M. Ohki, Genomics 35, 196 (1996).
3. H. Satoh et al., Mol. Carcinogen. 7, 157 (1993).
4. M. Negrini et al., Cancer Res. 54, 1331 (1994).
5. P. J. Saxon, E. S. Srivatsan, E. J. Stanbridge, EMBO J. 5, 3461 (1986).
6. B. E. Weissman et al., Science 236, 175 (1987).
7. S. S. Wang, A. F. Gazdar, J. D. Minna, G. A. Evans, unpublished data.
8. G. A. Evans, S. Atallah, S. S. Wang, Am. J. Hum. Genet. 59, A66 (1996).
9. T. Hunter, Cell 80, 225 (1995).
10. G. Walter and M. Mumby, Biochim. Biophys. Acta. 1155, 207 (1993).
11. P. A. Ioannou et al., Nature Genet. 6, 84 (1994).
12. S. S. Wang, L. Huang, J. Li, G. A. Evans, Am. J. Hum. Genet. 61, A87 (1997).
13. See the National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index, NCI-CGAP site at http://www.ncbi.nlm.nih.gov/CGAP.
14. B. A. Hemmings et al., Biochemistry 29, 3166 (1990).
15. Amplification was carried out with a 5′ RACE Kit (Boehringer Mannheim) and oligonucleotide primers 5′-TCACTTCGGGTCCTTTCTACTCCA-3′ and 5′-CTTCATTGCGGAGCTCGTCGA-3′. Amplification conditions were as follows: 95°C for 11 s. 59°C for 11 s, and 72°C for 15 s, for 33 cycles.
16. R. Ruediger, M. Hentz, J. Fait, M. Mumby, G. Walter, J. Virol. 68, 123 (1994).
17. RNA was prepared from lung cancer-derived and matched normal (lymphoblastoid) cell lines with the RNA/DNA STAT60 Kit (Tel-Test, Friendswood, TX). Primary tumor samples were obtained from the Cooperative Tissue Network (Birmingham, AL), and cancer cell lines were obtained from the American Type Culture Collection (ATCC) and A. Gazdar's lab. Randomly primed cDNA was synthesized with Superscript II (Gibco-BRL) and PCR was performed with the Expand Long Template PCR System (Boehringer Mannheim). In certain cases, nested PCR was performed with 20-fold-diluted amplification products from the initial PCR amplification. Primer pairs were as follows: 5′-GGTGACC-AGCAGCAGGAG-3′ and 5′-GCTTGGATGAGATC-TTGAAGGPCR-3′, 5′-GCGCATCAGAGCTCGGGACCG-3′ and 5′-CCATTCTTTCTCCACCCAGTTAAGAAC-3′. Amplification products were separated on 0.8% agarose gels, DNA bands were isolated with the QIA Quick Gel Extraction Kit (Qiagen, Santa Clarita, CA), and the DNA was sequenced with the Dye Terminator Sequencing Kit (Perkin-Elmer, Foster City, CA).
18. Gel-purified PCR products were cloned with the TOPO-TA Cloning Kit (Invitrogen, Carlsbad, CA). DNA from a single transformed colony was isolated and sequenced by means of automated DNA sequencing.
19. S. S. Wang et al., data not shown.
20. M. C. Mumby and G. Walter, Physiol. Rev. 73, 673 (1993).
21. J. Li et al., Science 275, 1943 (1997).
22. P. Steck et al., Nature Genet. 15, 356 (1997).
23. T. H. Lee, M. J. Solomon, M. C. Mumby, M. W. Kirschner, Cell 64, 415 (1991).
24. H. Li, L. L. Zhao, J. W. Funder, J. P. Liu, J. Biol. Chem. 272, 16729 (1997).
25. H. Fujiki and M. Suganuma, Adv. Cancer Res. 61, 143 (1993).
26. D. C. Pallas et al., Cell 60, 167 (1990).
27. E. Sontag et al., ibid. 75, 887 (1993).
28. T. Kawabe, A. J. Muslin, S. J. Korsmeyer, Nature 385, 454 (1997).
29. J. K. Heriche et al., Science 276, 952 (1997).
30. B. McCright, A. R. Brothman, D. M. Virshup, Genomics 36, 168 (1996).
31. Cells were lysed, proteins were separated by electrophoresis, and gels were transferred to Millipore Immobilon-P membrane. Immunodetection was carried out with goat anti-human PP2A-Aβ immunoglobulin and secondary horseradish peroxidase-conjugated donkey anti-goat immunoglobulin (Santa Cruz Biotechnology). Immunodetection was carried out with enhanced chemiluminescence (Amersham Life Sciences). Goat anti-human actin immunoglobulin was added as a control.
32. Cell lysates were immunoprecipitated with rabbit anti-human PP2A-C immunoglobulin (Promega) and protein C-agarose (Boehringer Mannheim). The precipitate was collected by centrifugation, and the pellet was washed with cold phosphate-buffered saline. The precipitate was then analyzed on an 8% SDS-polyacrylamide gel. Protein immunoblot detection was carried out with purified goat anti-human immunoglobulin against PP2A-Aβ and PP2A-C and secondary horseradish peroxidase-conjugated donkey anti-goat immunoglobulin (Santa Cruz Biotechnology).
33. We thank C. Richard III, M. Mumby, S. Federov, P. Ramos, J. Korcz, D. Stickens, V. Gee, and P. Schilling for assistance and helpful discussions. Supported by grants from NIH and the U.S. Department of Energy to G.A.E. and by a Lung Cancer SPORE grant from the National Cancer Institute to J.M. and A.G. E.D.E. was a predoctoral trainee of the Medical Scientist Training Program.